Global X Genomics & Biotechnology ETF
GNOM
GNOM
63 hedge funds and large institutions have $29.8M invested in Global X Genomics & Biotechnology ETF in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
Holders
63
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.29M | |
| 2 | +$1.04M | |
| 3 | +$1,000K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$701K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$267K |
Top Sellers
| 1 | -$4.43M | |
| 2 | -$1.36M | |
| 3 | -$574K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$265K |
| 5 |
BS
Banco Santander
Madrid,
Spain
|
-$183K |